12:00 AM
Mar 11, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Metasin test regulatory update

The U.K.'s NICE issued draft guidance recommending against use of TIB's Metasin test to detect sentinel lymph node metastases in patients with early invasive breast cancer who have a sentinel lymph...

Read the full 133 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >